Catalonia.health has formalized the renewal of its Board of Directors and appointed Eva García Ramos as the new president of the organization at the General Assembly held in L'Hospitalet de Llobregat.

Medichem Solutions S.L., a subsidiary of Medichem and a member of Catalonia.health, has announced a strategic collaboration with Breckenridge Pharmaceutical, Inc., a U.S.-based generic pharmaceutical company and subsidiary of Towa International.

Devicare, a leading pharmaceutical company in the field of urology and a member of Catalonia.health, has announced the acquisition of IP-6 International, Inc., a renowned North American nutritional supplement company and manufacturer of the IP6 Gold® brand. This operation represents Devicare's first acquisition outside Spain and constitutes a significant milestone in its international growth strategy.

The biotechnology company Orikine Bio, a member of Catalonia.health, has received €2.7 million in investment from SICC Innvierte of CDTI Innovación together with fund managers Asabys Partners (Sabadell Asabys Health Innovation Investments II, FCR and Sabadell Asabys Health Innovation Investments 2B, SCR SA) and AdBio Partners (AFB Seed Fund II), also members of Catalonia.health.

The Catalan ecosystem of emerging companies specialized in the health sector has achieved a new historic record in investment rounds. Funding raised through capital, grants and debt surged 60% year-on-year in 2025, reaching €378.2 million, with Catalonia.health member companies leading the main operations.

Asabys Partners, a venture capital firm based in Barcelona and a member of Catalonia.health, has announced the launch of Oriva Therapeutics, a company dedicated to developing innovative therapies in women's health. The new company has integrated two advanced assets from Oncostellae and Medibiofarma, targeting two chronic diseases with high unmet medical need: endometriosis and uterine fibroids.

Archivel Farma, a member of Catalonia.health, has announced the renewal of its GMP manufacturing certification, confirming compliance with the requirements of the new Annex 1 and Annex 2 to produce sterile, freeze-dried and biological products, in accordance with current European regulatory standards.

El passat 10 de febrer, catalonia.health va participar en la sessió "Explorant sinergies per a la salut global", una trobada de gran rellevància estratègica celebrada a ACCIÓ amb el Dr. Jarbas Barbosa da Silva Jr., director de la Pan American Health Organization (PAHO), l'organització que actua com a branca regional de la Organització Mundial de la Salut a l'hemisferi americà.

Els dies 8 i 9 de febrer, representants del sector biohealth català han participat en la segona edició delFIT4FUTURE Leaders Meeting celebrat a Bilbao, una trobada que ha reunit 14 territoris industrialsinnovadors d'Europa per definir el futur de la competitivitat industrial del continent.

Catalonia.health will participate in 4YFN 2026, the international event for startups and technology companies taking place from March 2 to 5 at Fira Gran Via in Barcelona, as part of the Mobile World Congress. 

The 12th edition brought together Catalonia's health ecosystem at the Gran Teatre del Liceu to celebrate innovation and the sector's collaborative spirit 

Barcelona, January 29, 2026 – Catalonia.health CEO Arantxa Sanz participated this week in the third edition of the "Life Sciences Innovation" conference series, co-organised with EY, which on this occasion explored the challenges and opportunities presented by the future regulation of medicines and medical products for the Spanish market.

HIPRA, a biotechnological company and member of Catalonia.health, and Elanco Animal Health have announced a strategic partnership to bring two vaccines against avian metapneumovirus (aMPV) to the United States poultry market.

The Catalan company Rob Surgical, specialising in robotic technology for minimally invasive surgery and a member of Catalonia.health, has inaugurated its first manufacturing plant in El Prat de Llobregat (Barcelona). 

The biotechnology company Inbiomotion,a member of Catalonia.health, has announced that its MAF Test® has been included in the SEOM-GEICAM-SOLTI 2025 Clinical Practice Guidelines for early-stage breast cancer, a key consensus document for clinical decision-making in Spain and an international reference.

CMG MedDev, a consulting company specialising in regulatory affairs, quality management and clinical consulting for medical devices, in vitro diagnostics and solutions based on software and artificial intelligence, and a member of Catalonia.health, has been awarded the 2025 Cum Laude Award for Innovation in Regulatory Consulting for Medical Devices. 

Barcelona, November 2025 – Catalonia.health hosted this November a working visit by the European consortium RISEMED4EU (Regional Innovation for Smart Ecosystems in Health and Medicine in the EU), an initiative bringing together eight regions from eight European countries with the aim of boosting innovation in health and personalised medicine through interregional collaboration and advanced technology

The technology centre Eurecat, a member of Catalonia.health, and the Catalan Institute of Oncology (ICO) have launched a pilot test of a digital platform based on artificial intelligence aimed at promoting healthy habits and emotional management in order to contribute to primary cancer prevention.  

The biopharmaceutical company Oniria Therapeutics, a member of Catalonia.health, is collaborating with the Vall d’Hebron Institute of Oncology (VHIO) and the Institute of Chemical Research of Catalonia (ICIQ) on the development of the innovative drug ONR-001, aimed at the treatment of treatment-resistant colorectal cancer.

The biopharmaceutical company Oryzon Genomics, a member of Catalonia.health, has presented new clinical data on iadademstat in patients with acute myeloid leukaemia (AML) at the 67thAnnual Meeting of the American Society of Hematology (ASH).